U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C26H41NO
Molecular Weight 383.6098
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of Melinamide

SMILES

CCCCC\C=C/C\C=C/CCCCCCCC(=O)NC(C)C1=CC=CC=C1

InChI

InChIKey=RWIUTHWKQHRQNP-NQLNTKRDSA-N
InChI=1S/C26H41NO/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(28)27-24(2)25-21-18-17-19-22-25/h7-8,10-11,17-19,21-22,24H,3-6,9,12-16,20,23H2,1-2H3,(H,27,28)/b8-7-,11-10-

HIDE SMILES / InChI

Molecular Formula C26H41NO
Molecular Weight 383.6098
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 2
Optical Activity ( + / - )

Description

Melinamide is an antilipidemic agent similar to gemfibrozil. It acts to lower elevated serum lipids by reducing the very low-density lipoprotein fraction rich in triglycerides. Serum cholesterol may be decreased, particularly in those patients whose cholesterol elevation is due to the presence of IDL as a result of Type III hyperlipoproteinemia. Melinamide caused a decrease of the enhanced intestinal ACAT activity in diabetic rats, but did not affect intestinal cholesterol esterase activity. Marked improvement of hypercholesterolaemia in cholesterol-fed diabetic rats occurred concomitantly with the drug treatment. These results suggest that intestinal ACAT activity is closely related to the serum cholesterol level in diabetic rats, and show that melinamide lowers intestinal ACAT activity. Melinamide (Artes®) was the only marketed (in Japan) ACAT inhibitor. 04 Aug 2004 was withdrawn for Hypercholesterolaemia in Japan.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
3.2 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Artes

Approved Use

Hypercholesterolaemia
PubMed

PubMed

TitleDatePubMed
N-[2-[N'-pentyl-(6,6-dimethyl-2,4-heptadiynyl)amino]ethyl]- (2-methyl-1-naphthylthio)acetamide (FY-087). A new acyl coenzyme a:cholesterol acyltransferase (ACAT) inhibitor of diet-induced atherosclerosis formation in mice.
1995-03-01
In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT.
1993-02
Contribution of peroxisomal beta-oxidation system to the chain-shortening of N-(alpha-methylbenzyl)azelaamic acid in rat liver.
1990-06-15
Cholesterol-lowering effect of N-(alpha-methylbenzyl)linoleamide (melinamide) in cholesterol-fed diabetic rats.
1988-08
Influence of 5-tridecylpyrazole-3-carboxylic acid, a new hypolipidaemic agent, on cholesteryl ester formation in rabbit intestinal mucosa.
1988-07
Inhibitory effect of melinamide on cholesterol solubility in mixed micellar solution of sodium taurocholate.
1986-10
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Melinamide significantly inhibited ACAT in the range of 20 to 100 uM
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:37:21 GMT 2025
Edited
by admin
on Mon Mar 31 18:37:21 GMT 2025
Record UNII
JJ07049A84
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Melinamide
INN   JAN   MART.   MI   WHO-DD  
INN  
Official Name English
ARTES
Preferred Name English
DL-N-(.ALPHA.-METHYLBENZYL)LINOLEAMIDE
Common Name English
AC-223
Code English
MBLA
Common Name English
melinamide [INN]
Common Name English
MELINAMIDE [MART.]
Common Name English
9,12-OCTADECADIENAMIDE, N-(1-PHENYLETHYL)-, (9Z,12Z)-
Systematic Name English
DL-.ALPHA.-METHYLBENZYL LINOLEAMIDE
Common Name English
LINOLEAMIDE, N-(.ALPHA.-METHYLBENZYL)-
Systematic Name English
9,12-OCTADECADIENAMIDE, N-(1-PHENYLETHYL)-, (Z,Z)-
Systematic Name English
MELINAMIDE [JAN]
Common Name English
N-(.ALPHA.-METHYLBENZYL)LINOLEAMIDE
Systematic Name English
MELINAMIDE [MI]
Common Name English
Melinamide [WHO-DD]
Common Name English
N-(DL-.ALPHA.-METHYLBENZYL) LINOLEAMIDE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C471
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
Code System Code Type Description
FDA UNII
JJ07049A84
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
MERCK INDEX
m7160
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY Merck Index
PUBCHEM
20054967
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
CAS
14417-88-0
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
NCI_THESAURUS
C87732
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
EPA CompTox
DTXSID9048809
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
INN
2993
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
ChEMBL
CHEMBL2104478
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
CAS
20917-22-0
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
SUPERSEDED
SMS_ID
100000081467
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
MESH
C001757
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
EVMPD
SUB08724MIG
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
DRUG CENTRAL
1674
Created by admin on Mon Mar 31 18:37:21 GMT 2025 , Edited by admin on Mon Mar 31 18:37:21 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY